Long-term epilepsy-associated tumors

The goal of this review is to summarize data concerning radiological and histological diagnosis of epileptogenic tumors, as well as to discuss their surgical treatment. PubMed literature database was searched for relevant articles, we also used our own clinical experience. Benign glioneuronal tumors...

Full description

Saved in:
Bibliographic Details
Published inZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova Vol. 122; no. 4; p. 127
Main Authors Kopachev, D N, Shishkina, L V, Shkatova, A M, Golovteev, A L, Troitsky, A A, Grinenko, O A, Sharkova, S M, Petrosyan, D V, Gushcha, A O
Format Journal Article
LanguageRussian
Published Russia (Federation) 2022
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:The goal of this review is to summarize data concerning radiological and histological diagnosis of epileptogenic tumors, as well as to discuss their surgical treatment. PubMed literature database was searched for relevant articles, we also used our own clinical experience. Benign glioneuronal tumors are the second most common cause of drug resistant epilepsy in adults after hippocampal sclerosis. Exceptionally slow growth (more than 2 years), localization in the brain cortex, presence of differentiated neuronal tissue in tumoral body and long history of epilepsy are the key features of these tumors called LEAT (long-term epilepsy-associated tumors). Management of LEAT requires epileptological as well as neurooncological approach. The epileptogenic zone commonly spreads beyond the tumor borders and simple lesionectomy alone may not be sufficient for achieving seizure freedom. LEAT typically exhibit low proliferative activity, however they should be thoroughly differentiated from more aggressive glial tumors; while this task is sometimes quite challenging, it's achievable by means of histological and immunohistochemical examination.
ISSN:1997-7298
DOI:10.17116/jnevro2022122041127